Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Haas Jason
Over the trailing 90 days, Haas Jason (Director at LIGAND PHARMACEUTICALS INC) traded $1.9M of stock (net selling $1.4M) across 2 companies, per 9 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 9 transactions · CIK 1883821
- Net activity
- −$1.4M ($226K bought · $1.7M sold)
By Company (Trailing 90 Days)
Transactions (9)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-12 | LGND | Sell | 1.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-12 | LGND | Sell | 3.5K | $886K | Open market or private sale |
| 2026-06-12 | LGND | Sell | 3.0K | $765K | Open market or private sale |
| 2026-06-12 | LGND | Buy | 1.0K | $52K | Exercise or conversion of derivative security |
| 2026-06-12 | LGND | Buy | 3.0K | $155K | Exercise or conversion of derivative security |
| 2026-06-12 | LGND | Sell | 3.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-05 | LGND | Buy | 836 | $0 | Grant, award or other acquisition |
| 2026-06-05 | LGND | Buy | 2.9K | $0 | Grant, award or other acquisition |
| 2026-05-08 | ODTX | Buy | 1.0K | $20K | Open market or private purchase |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Haas's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.